Plasmodium vivax infection during pregnancy: An important problem in need of new solutions

Clinical Infectious Diseases

Volumn 46, Issue 9, 2008, Pages 1382-1384

  Ter Kuile, Feiko O ^a   Rogerson, Stephen J ^b  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

CLINICAL TRIAL; HUMAN; MALARIA; MATERNAL MORTALITY; MORBIDITY; NONHUMAN; NOTE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREGNANCY; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; FEMALE; HUMANS; INDONESIA; MALARIA, VIVAX; PARASITEMIA; PLASMODIUM VIVAX; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME;

EID: 42549109201     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/586744     Document Type: Note

References (21)

1. Baird JK. Neglect of Plasmodium vivax malaria. Trends Parasitol 2007; 23:533-9.
2. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004; 4:327-36.
3. Dobson MJ. Malaria in England: a geographical and historical perspective. Parassitologia 1994; 36:35-60.
4. Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007; 77:984-91.
5. Anstey NM, Handojo T, Pain MC, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 2007; 195:589-96.
6. Poespoprodjo JR, Fobia W, Kenangalem E, et al. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 2008; 46:1374-81 (in this issue).
7. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104.
8. Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 2004; 20:425-32.
9. Duffy PE, Desowitz RS. Pregnancy malaria throughout history: dangerous labors. In: Duffy PE, Fried M, eds. Malaria in pregnancy: deadly parasite, susceptible host. London:Taylor & Francis, 2001:1-26.
10. Singh N, Shukla MM, Sharma VP. Epidemiology of malaria in pregnancy in central India. Bull World Health Organ 1999; 77:567-72.
11. Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354:546-9.
12. Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta - the role of malaria. Placenta 2004; 25:359-78.
13. Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 2007; 7:105-17.
14. McGready R, Davison BB, Stepniewska K, et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am J Trop Med Hyg 2004; 70:398-407.
15. World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: World Health Organization Regional Office for Africa, 2004.
16. Gamble C, Ekwaru PJ, Garner P, ter Kuile FO. Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Med 2007; 4:e107.
17. Villegas L, McGready R, Htway M, et al. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Trop Med Int Health 2007; 12:209-18.
18. Kayentao K, Kodio M, Newman RD, et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 2005; 191:109-16.
19. Ratcliff A, Siswantoro H, Kenangalem E, et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 2007; 369:757-65.
20. Hasugian AR, Purba HL, Kenangalem E, et al. Dihydroartemisinin- piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis 2007; 44:1067-74.
21. Price RN, Hasugian AR, Ratcliff A, et al. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Antimicrob Agents Chemother 2007; 51:4090-7.